These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4574661)

  • 1. 2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
    Fujimori M
    Cancer; 1973 Apr; 31(4):789-92. PubMed ID: 4574661
    [No Abstract]   [Full Text] [Related]  

  • 2. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
    Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat.
    Takatani O; Kumaoka S
    Gan; 1977 Jun; 68(3):337-41. PubMed ID: 913955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithioandrostanol on mammary tumors of rats and mice.
    Takatani O; Kumaoka S; Yamaguchi K
    Gan; 1973 Jun; 64(3):305-7. PubMed ID: 4730599
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic value of mepitiostane in the treatment of advanced breast cancer.
    Inoue K; Okazaki K; Morimoto T; Hayashi M; Uyama S; Sonoo H; Koshiba Y; Takihara T; Nomura Y; Yamagata J; Kondo H; Kanda K; Takenaka K
    Cancer Treat Rep; 1978 May; 62(5):743-5. PubMed ID: 657160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay.
    Nomura Y; Yamagata J; Kondo H; Takenaka K
    Gan; 1978 Apr; 69(2):281-2. PubMed ID: 680466
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesterolone: a new androgen.
    Drug Ther Bull; 1972 Jul; 10(15):58-9. PubMed ID: 5073836
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
    Izuo M; Okada T; Suemasu K; Fujimori M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):509. PubMed ID: 4476537
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgenic therapy for advanced breast cancer in women. A report of the cooperative breast cancer group.
    Goldenberg IS; Waters N; Ravdin RS; Ansfield FJ; Segaloff A
    JAMA; 1973 Mar; 223(11):1267-8. PubMed ID: 4739330
    [No Abstract]   [Full Text] [Related]  

  • 10. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
    Miyake T; Hori T; Kato G; Ide M; Uchida N; Yamaguchi K
    Steroids; 1974 Jun; 23(6):929-37. PubMed ID: 4836439
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
    Iwai K; Honda H; Yamada S; Fukase M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):501. PubMed ID: 4476529
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of high doses of mesterolone on the spermiogram.
    Schellen TM; Beek JM
    Fertil Steril; 1972 Oct; 23(10):712-4. PubMed ID: 4651622
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (epitiostanol) on hypothalamo-pituitary-gonadal axis in humans.
    Kurachi K; Aono T; Tomoyama J; Matsumoto K; Nakasima A
    Acta Obstet Gynaecol Jpn; 1975 Jan; 22(1):42-8. PubMed ID: 1224948
    [No Abstract]   [Full Text] [Related]  

  • 14. Onset of puberty in the immature female rat induced by 5 -androstane-3 ,17 -diol.
    Eckstein B; Golan R; Shani J
    Endocrinology; 1973 Mar; 92(3):941-5. PubMed ID: 4735653
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the edemato-ascitic syndrome with an injectable aldosterone antagonist: 8109 CB].
    Dubarry JJ; Bancons J; Quinton A
    Bord Med; 1971 Dec; 4(12):3751-7. PubMed ID: 5146181
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancer.
    Eur J Cancer (1965); 1972 Aug; 8(4):387-9. PubMed ID: 4561336
    [No Abstract]   [Full Text] [Related]  

  • 17. Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone.
    Pochi PE; Strauss JS
    J Invest Dermatol; 1969 Jan; 52(1):32-6. PubMed ID: 4236132
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and secretion of 5alpha-androstan-17beta-ol-3-one, 5alpha-androstan-3alpha,17beta-diol and 5alpha-androstan-3beta,17beta-diol by the perfused rabbit testis epididymis.
    Ewing L; Brown B
    Endocrinology; 1975 Feb; 96(2):479-85. PubMed ID: 1112261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy.
    Izuo M; Fujimori M
    Endocrinol Jpn; 1968 Sep; 15(3):371-4. PubMed ID: 4237209
    [No Abstract]   [Full Text] [Related]  

  • 20. Epithioandrostanol(10275-S), an estrogen antagonist.
    Miyake T; Hori T; Suzuki T
    Endocrinol Jpn; 1973 Apr; 20(2):157-65. PubMed ID: 4740596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.